Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States
Dr. Lindenfeld is a Heart Failure/Transplant Cardiologist at Vanderbilt University Medical Center. She has over 30 years experience with clinical trials and has served on the FDA Cardiorenal and Devices Panel. She has written the HFSA heart failure guidlines and has been a member of the AHA/ACC/HFSA Guidelines. Her main area of research is the use of devices in heart failure.
Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Percutaneous Mitral Valve Therapy
Sunday, March 9, 2025
10:40 AM – 10:50 AM ET
Panel Discussion and Questions
Sunday, March 9, 2025
11:55 AM – 12:15 PM ET
Sunday, March 9, 2025
3:15 PM – 4:35 PM ET
Sunday, March 9, 2025
4:20 PM – 4:35 PM ET